Skip to main navigation Skip to search Skip to main content

Osimertinib in patients with epidermal growth factor receptor mutation-positive non-small-cell lung cancer and leptomeningeal metastases: The BLOOM study

  • James C.H. Yang
  • , Sang We Kim
  • , Dong Wan Kim
  • , Jong Seok Lee
  • , Byoung Chul Cho
  • , Jin Seok Ahn
  • , Dae H. Lee
  • , Tae Min Kim
  • , Jonathan W. Goldman
  • , Ronald B. Natale
  • , Andrew P. Brown
  • , Barbara Collins
  • , Juliann Chmielecki
  • , Karthick Vishwanathan
  • , Ariadna Mendoza-Naranjo
  • , Myung Ju Ahn
  • National Taiwan University
  • University of Ulsan
  • Seoul National University
  • Yonsei University
  • University of California at Los Angeles
  • Cedars-Sinai Medical Center
  • AstraZeneca

Research output: Contribution to journal › Article › peer-review

373   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Osimertinib in patients with epidermal growth factor receptor mutation-positive non-small-cell lung cancer and leptomeningeal metastases: The BLOOM study'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science